179 related articles for article (PubMed ID: 31420586)
1. Development of a nebramine-cyclam conjugate as an antibacterial adjuvant to potentiate β-lactam antibiotics against multidrug-resistant P. aeruginosa.
Ammeter D; Idowu T; Zhanel GG; Schweizer F
J Antibiot (Tokyo); 2019 Nov; 72(11):816-826. PubMed ID: 31420586
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinations against MDR and XDR Pseudomonas aeruginosa using non-ribosomal tobramycin-cyclam conjugates.
Idowu T; Ammeter D; Arthur G; Zhanel GG; Schweizer F
J Antimicrob Chemother; 2019 Sep; 74(9):2640-2648. PubMed ID: 31139830
[TBL] [Abstract][Full Text] [Related]
3. Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
Yang X; Ammeter D; Idowu T; Domalaon R; Brizuela M; Okunnu O; Bi L; Guerrero YA; Zhanel GG; Kumar A; Schweizer F
Eur J Med Chem; 2019 Aug; 175():187-200. PubMed ID: 31078866
[TBL] [Abstract][Full Text] [Related]
4. Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant
Dhiman S; Ramirez D; Li Y; Kumar A; Arthur G; Schweizer F
ACS Infect Dis; 2023 Apr; 9(4):864-885. PubMed ID: 36917096
[TBL] [Abstract][Full Text] [Related]
5. Overcoming β-Lactam resistance in Pseudomonas aeruginosa using non-canonical tobramycin-based antibiotic adjuvants.
Idowu T; Ammeter D; Brizuela M; Jackson G; Alam S; Schweizer F
Bioorg Med Chem Lett; 2020 Nov; 30(21):127575. PubMed ID: 32980511
[TBL] [Abstract][Full Text] [Related]
6. Trimeric Tobramycin/Nebramine Synergizes β-Lactam Antibiotics against
Dhiman S; Ramirez D; Arora R; Gandhi K; Wimalasekara R; Arthur G; Kumar A; Schweizer F
ACS Omega; 2023 Aug; 8(32):29359-29373. PubMed ID: 37599980
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
[No Abstract] [Full Text] [Related]
8. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
9. Guanidinylated Amphiphilic Tobramycin Derivatives Synergize with β-Lactam/β-Lactamase Inhibitor Combinations against
Ramirez DM; Ramirez D; Dhiman S; Arora R; Lozeau C; Arthur G; Zhanel G; Schweizer F
ACS Infect Dis; 2023 Sep; 9(9):1754-1768. PubMed ID: 37603592
[TBL] [Abstract][Full Text] [Related]
10. Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy.
Gorityala BK; Guchhait G; Fernando DM; Deo S; McKenna SA; Zhanel GG; Kumar A; Schweizer F
Angew Chem Int Ed Engl; 2016 Jan; 55(2):555-9. PubMed ID: 26610184
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development.
Lamers RP; Burrows LL
Future Med Chem; 2016 Jun; 8(9):975-92. PubMed ID: 27228070
[TBL] [Abstract][Full Text] [Related]
12. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance.
Li XZ; Ma D; Livermore DM; Nikaido H
Antimicrob Agents Chemother; 1994 Aug; 38(8):1742-52. PubMed ID: 7986004
[TBL] [Abstract][Full Text] [Related]
13. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.
Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289035
[TBL] [Abstract][Full Text] [Related]
14. Overcoming Multidrug Resistance and Biofilms of
Lam AK; Panlilio H; Pusavat J; Wouters CL; Moen EL; Rice CV
ACS Infect Dis; 2020 May; 6(5):1085-1097. PubMed ID: 32223216
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa.
Song W; Woo HJ; Kim JS; Lee KM
Int J Antimicrob Agents; 2003 Jan; 21(1):8-12. PubMed ID: 12507832
[TBL] [Abstract][Full Text] [Related]
16. New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship.
Jean SS; Gould IM; Lee WS; Hsueh PR;
Drugs; 2019 May; 79(7):705-714. PubMed ID: 30972660
[TBL] [Abstract][Full Text] [Related]
17. Heterodimeric Rifampicin-Tobramycin conjugates break intrinsic resistance of Pseudomonas aeruginosa to doxycycline and chloramphenicol in vitro and in a Galleria mellonella in vivo model.
Idowu T; Arthur G; Zhanel GG; Schweizer F
Eur J Med Chem; 2019 Jul; 174():16-32. PubMed ID: 31022550
[TBL] [Abstract][Full Text] [Related]
18. Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa.
Hancock RE; Woodruff WA
Rev Infect Dis; 1988; 10(4):770-5. PubMed ID: 2460909
[TBL] [Abstract][Full Text] [Related]
19. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
Oie S; Sawa A; Kamiya A; Mizuno H
J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
